AU Patent

AU2006243859A1 — Crystalline form of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments

Assigned to Boehringer Ingelheim International GmbH · Expires 2006-11-09 · 20y expired

What this patent protects

Patent listed against Jardiance.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006243859A1
Jurisdiction
AU
Classification
—
Expires
2006-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.